Insurancenewsnet.com

Endo Pharmaceuticals Receives FDA Approval for FORTESTA™ (Testosterone) Gel as a Class III Product for Topical Use for Men with Low Testosterone

CHADDS FORD, Pa., Dec. 29, 2010 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that the U.S. Food and Drug Administration (FDA) has ...
Reuters

US OKs Endo, Prostrakan testosterone gel

WASHINGTON, Dec 29 (Reuters) - U.S. health regulators have approved Endo Pharmaceuticals Holding Inc and ProStrakan Group PLC's Fortesta testosterone gel to treat men with low levels of the hormone.
Reuters

U.S. approves Endo, Prostrakan testosterone gel

WASHINGTON (Reuters) - U.S. health regulators have approved Endo Pharmaceuticals Holding Inc and ProStrakan Group PLC's Fortesta testosterone gel to treat men with low levels of the hormone. The gel ...
BioWorld

$210M Deal Gives Endo Rights to Testosterone Gel Fortesta

With an FDA decision drawing near for testosterone gel Fortesta, Endo Pharmaceuticals Inc. has grabbed marketing rights to the hormone replacement therapy in the U.S. under a deal valued at up to $210 ...
Washington Examiner

FDA reviews safety of testosterone therapy for men

WASHINGTON (AP) — The Food and Drug Administration said Friday it is reviewing the safety of popular testosterone drugs for men in light of recent studies suggesting they can increase the risk of ...